or Try an Advanced Search...

    Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 7.46 -0.53% -0.04
    RXRX closed down 0.53 percent on Monday, July 1, 2024, on 1.42 times normal volume.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical RXRX trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Volume Surge Other -0.53%
    Calm After Storm Range Contraction -0.53%
    NR7 Range Contraction -0.53%
    Lower Bollinger Band Walk Weakness -0.53%
    Older End-of-Day Signals for RXRX ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 5 hours ago
    60 Minute Opening Range Breakdown about 6 hours ago
    Possible NR7 about 6 hours ago
    60 Minute Opening Range Breakout about 10 hours ago
    Up 5% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RXRX Chart by TradingView
    Basic chart:

    Profile

    Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare

    Is RXRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Recursion Pharmaceuticals stock slides on pricing stock offering to raise $200 million
    Jun 27 Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
    Jun 26 Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
    Jun 26 Recursion announces proposed offering of class A common stock
    Jun 26 Recursion Announces Proposed Offering of Class A Common Stock
    Jun 25 Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
    Jun 25 Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening?
    Jun 24 What's Going On With Recursion Pharmaceuticals Stock Monday?
    Jun 24 Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day
    Jun 24 Recursion Pharmaceuticals: More Of A TechBio Industrializing Drug Discovery
    See more RXRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.745
    52 Week Low 4.97
    Average Volume 5,731,547
    200-Day Moving Average 8.91
    50-Day Moving Average 8.76
    20-Day Moving Average 8.79
    10-Day Moving Average 8.71
    Average True Range 0.69
    RSI (14) 35.06
    ADX 18.64
    +DI 21.42
    -DI 32.68
    Chandelier Exit (Long, 3 ATRs) 7.92
    Chandelier Exit (Short, 3 ATRs) 8.82
    Upper Bollinger Bands 10.08
    Lower Bollinger Band 7.51
    Percent B (%b) -0.02
    BandWidth 29.19
    MACD Line -0.26
    MACD Signal Line -0.06
    MACD Histogram -0.1994
    Fundamentals Value
    Market Cap 1.55 Billion
    Num Shares 208 Million
    EPS -1.46
    Price-to-Earnings (P/E) Ratio -5.11
    Price-to-Sales 49.87
    Price-to-Book 4.88
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.30
    Resistance 3 (R3) 8.37 8.16 8.16
    Resistance 2 (R2) 8.16 7.95 8.13 8.11
    Resistance 1 (R1) 7.81 7.81 7.71 7.74 8.07
    Pivot Point 7.60 7.60 7.55 7.57 7.60
    Support 1 (S1) 7.25 7.39 7.15 7.18 6.85
    Support 2 (S2) 7.04 7.25 7.01 6.81
    Support 3 (S3) 6.69 7.04 6.76
    Support 4 (S4) 6.62